Six Resolutions Mesothelioma Patients Should Make in 2018

The New Year is often a time to set new goals and make plans. While it is important for mesothelioma patients and their families to fully embrace the present, there are also some goals worth setting, even if the prognosis seems grim. The following six New Year’s resolutions can help ensure the best possible quality of life and treatment outcomes for people battling malignant mesothelioma … Continue reading Six Resolutions Mesothelioma Patients Should Make in 2018 »

Mindfulness May Help Mesothelioma Patients Cope

There is new evidence that lung cancer patients who receive training in mindfulness can dramatically lower their feelings of stress and anxiety. Lung-related cancers like pleural mesothelioma and non-small cell lung cancer have been shown to produce some of the highest levels of anxiety of any cancer. Although there are differences between the asbestos cancer malignant mesothelioma and other types of lung cancer, both malignancies tend … Continue reading Mindfulness May Help Mesothelioma Patients Cope »

Breath​ ​Test​ ​May​ ​Finally​ ​Offer​ ​a​ ​Way​ ​to​ ​Screen​ ​for​ ​Pleural​ ​Mesothelioma

Earlier diagnosis of malignant pleural mesothelioma may be just a breath away. A new Belgian study shows that two kinds of breath-analyzing tests may finally offer an accurate way to screen for the deadly asbestos cancer. An accurate screening tool could lead to earlier mesothelioma diagnosis, earlier intervention, and, potentially, better treatment outcomes. Pleural mesothelioma is an extremely rare but aggressive cancer caused almost exclusively … Continue reading Breath​ ​Test​ ​May​ ​Finally​ ​Offer​ ​a​ ​Way​ ​to​ ​Screen​ ​for​ ​Pleural​ ​Mesothelioma »

Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery

Researchers at MD Anderson Cancer Center say they may have found a way to help predict which peritoneal mesothelioma patients are most likely to develop complications after cytoreductive surgery and intraperitoneal chemotherapy. Cytoreductive surgery to remove as much of a mesothelioma tumor as possible, followed by a rinse of heated chemotherapy drugs in the abdomen is known as CRS + HIPEC. It has become a … Continue reading Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery »

Immune System Changes Could Signal Mesothelioma Risk

The state of an asbestos-exposed person’s immune system might give doctors clues about how likely they are to develop malignant mesothelioma. It’s a fear for any person who has worked around asbestos – that one day they may develop the asbestos-linked cancer, mesothelioma. Pleural mesothelioma can take decades to develop, causes few symptoms at first, and is extremely hard to treat. Right now, there is … Continue reading Immune System Changes Could Signal Mesothelioma Risk »

Improving Communication for Mesothelioma Patients and Providers

When it comes to communicating with malignant mesothelioma patients and their families, a longitudinal approach where patients are followed throughout their cancer journey may be most effective. That is the suggestion of a lung  cancer communication study newly published in the European Journal of Cancer Care. Researchers at the University of Heidelberg in Germany and the University of Utah Population Health Sciences Department conducted interviews … Continue reading Improving Communication for Mesothelioma Patients and Providers »

Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy

A new study is casting some doubt on the value of a protein called PD-L1 as a way to select mesothelioma patients for targeted immunotherapy. Several of the most promising new treatments for malignant mesothelioma, including pembrolizumab (Keytruda) and avelumab (Avastin), are designed to inhibit PD-L1, a protein cells used to evade detection by the immune system. PD-L1 inhibitors like Keytruda have become an important … Continue reading Study Highlights Challenge of Selecting Patients for Mesothelioma Immunotherapy »

Better Nutrition Could Mean Longer Survival for Elderly Mesothelioma Patients

Could eating better improve elderly patient’s chances of surviving malignant pleural mesothelioma? Another new study suggests that it may. An article in the journal Surgical Oncology found that lung cancer patients who score low on a nutritional status assessment tool called the Geriatric Nutritional Risk Index (GNRI) have worse outcomes after surgery. The GNRI is a simple tool based on weight and levels of the … Continue reading Better Nutrition Could Mean Longer Survival for Elderly Mesothelioma Patients »

Immunotherapy for Mesothelioma: Who Are the Best Candidates?

Immunotherapy is emerging as one of the most promising new treatment approaches for a wide range of cancers, including malignant pleural mesothelioma, the treatment-resistant lung-related cancer caused by asbestos exposure. Every year, more than 2,500 Americans are diagnosed with pleural mesothelioma. Most will die of the illness within 18 months, even with the most advanced chemotherapeutic, radiotherapeutic, and surgical treatments. But immunotherapy, which recruits the … Continue reading Immunotherapy for Mesothelioma: Who Are the Best Candidates? »

FGFR Inhibitors May Offer New Way to Treat Malignant Pleural Mesothelioma

Drugs that inhibit a particular cell signaling pathway might offer a new way to help treat the intractable asbestos cancer, malignant mesothelioma. Fibroblast growth factor receptor (FGFR) is a tyrosine kinase signaling pathway that plays a fundamental role in the development of embryos, tissue regeneration, and the growth of new blood vessels (angiogenesis). Recent evidence suggests that it may also impact the development of cancers … Continue reading FGFR Inhibitors May Offer New Way to Treat Malignant Pleural Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!